March 16, 2013
Courses for October 2013
Course Provider: FDA Academy (FDA Philippines)
Title: Licensing Seminar on A.O. 56 for Drug Outlets and Drug Establishments
(Manufacturers and Traders)
Course Design: A 2-day course required for LTO of drug manufacturers and traders.(Manufacturers and Traders)
Date: October 3-4, 2013 - FULL
Remarks: Course Fee is Php 6,000.00. Limited to 70 participants per session
Course Provider: FDA Academy (FDA Philippines)
Registration Procedure
Terms and Conditions
________________________________________
Title: 13 ASEAN Modules GMP for Cosmetic Manufacturers (Toilet Soap)
Course Design: A 2-day course designed for cosmetic manufacturers of toilet soap.
Date: October 21- 22, 2013
Remarks: Course fee is Php 6,000.00. Limited to 70 participants per session.
Course Provider: FDA Academy (FDA Philippines)
Registration Procedure
Terms and Conditions
________________________________________
Title: Common Submission Dossier Template (CSDT) Training
Course Design: A 1-day harmonized technical regulatory requirements for medical device industry in the ASEAN region.
Date: October 16. 2013
Remarks: Course fee is Php 3,000.00. Limited to 50 participants per session.
Course Provider: FDA Academy (FDA Philippines)
Policy and Planning Office at Tel. nos. +62 2 809 5045 local 8302 or email them your queries in academy@fda.fov.ph
You can also drop by at their office.
Room AB-313, 3rd Floor Annex Building, Civic Drive, Filinvest Corporate City, Alabang, Muntinlupa, 1781 Philippines.
Source: FDA Academy (FDA Philipines)
Disclaimer:
The information and reference materials contained here are intended solely for the general information of the reader and NOT intended to replace the official advisory. We are only helping the FDA Philippines in disseminating these announcements. The owner of this site disclaims any responsibility for the decisions you make based on this information.
No comments:
Post a Comment
I'd love to hear your thoughts. Please drop a line here and do come back as I will do all my best to reply to your comments.